SMMT: Summit Therapeutics Inc. Stock

by  •  • Comments Off on SMMT: Summit Therapeutics Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 27,072.85
Enterprise Value ($M) 26,685.05
Book Value ($M) 388.70
Book Value / Share 0.53
Price / Book 69.65
NCAV ($M) 365.40
NCAV / Share 0.50
Price / NCAV 74.09

Profitability (mra)
Return on Invested Capital (ROIC) -0.53
Return on Assets (ROA) -1.25
Return on Equity (ROE) -5.01

Liquidity (mrq)
Quick Ratio 9.88
Current Ratio 9.88

Balance Sheet (mrq) ($M)
Current Assets 412.30
Assets 435.60
Liabilities 46.90
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -211.00
Net Income -221.30

Cash Flow Statement (mra) ($M)
Cash From Operations -142.10
Cash from Investing -205.30
Cash from Financing 381.20

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
09-13 13D/A Duggan Robert W 75.20 216.00

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-05-01 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-04-25 6,146,626 23,575,339 26.07
2025-04-24 1,952,841 7,098,339 27.51
2025-04-23 2,851,922 10,626,338 26.84
2025-04-22 854,811 4,164,294 20.53

(click for more detail)

Similar Companies
SGMT – Sagimet Biosciences Inc. SIGA – SIGA Technologies, Inc.
SKYE – Skye Bioscience, Inc. SPRY – ARS Pharmaceuticals, Inc.
STRO – Sutro Biopharma, Inc.


Financial data and stock pages provided by
Fintel.io